BiotechTube
Home/GT Biopharma/Jeffrey S. Miller, M.D.
JS

Jeffrey S. Miller, M.D.

Consulting Senior Medical Director

GT Biopharma

Therapeutic Areas

OncologyImmunology

GT Biopharma Pipeline

DrugIndicationPhase
GTB-3650 TriKE®Relapsed/Refractory CD33+ hematologic malignancies (Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome)Phase 1
GTB-5550 TriKE®Metastatic Solid Tumors (Basket: Prostate, Ovarian, Breast, Head & Neck, NSCLC, Pancreatic, Bladder Cancers)Phase 1 (Planned)

Leadership Team at GT Biopharma

MB
Michael Breen
Executive Chairman, Board of Directors, Chief Executive Officer
AL
Alan L. Urban
Chief Financial Officer
View full GT Biopharma profile